
G2GBIO, Inc. — Investor Relations & Filings
G2GBIO, Inc. is a biotechnology company specializing in sustained-release pharmaceuticals through its proprietary drug delivery system platform. The company's core technology, InnoLAMP (Innovative Long-Acting MicroParticle), is used to develop long-acting injectable microspheres that provide a controlled, extended release of therapeutic agents. This platform aims to improve treatment efficacy and patient compliance for chronic diseases by reducing dosing frequency. G2GBIO's research and development pipeline is focused on creating long-acting formulations for conditions including Alzheimer's disease, Type 2 diabetes, schizophrenia, and post-operative pain. The company also develops specialized applications for targeted drug delivery in areas such as oncology.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| [기재정정]임원ㆍ주요주주특정증권등소유상황보고서 | 2026-05-22 | Korean | |
| 임원ㆍ주요주주특정증권등소유상황보고서 | 2026-05-21 | Korean | |
| 임원ㆍ주요주주특정증권등소유상황보고서 | 2026-05-21 | Korean | |
| 임원ㆍ주요주주특정증권등소유상황보고서 | 2026-05-21 | Korean | |
| 분기보고서 (2026.03) | 2026-05-15 | Korean | |
| 기업설명회(IR)개최 | 2026-04-14 | Korean |
Browse filings by year
5 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 46793439 | [기재정정]임원ㆍ주요주주특정증권등소유상황보고서 | 2026-05-22 | Korean | ||
| 46724997 | 임원ㆍ주요주주특정증권등소유상황보고서 | 2026-05-21 | Korean | ||
| 46724826 | 임원ㆍ주요주주특정증권등소유상황보고서 | 2026-05-21 | Korean | ||
| 46724723 | 임원ㆍ주요주주특정증권등소유상황보고서 | 2026-05-21 | Korean | ||
| 46357871 | 분기보고서 (2026.03) | 2026-05-15 | Korean | ||
| 34470228 | 기업설명회(IR)개최 | 2026-04-14 | Korean | ||
| 34470225 | 기업설명회(IR)개최 | 2026-04-14 | Korean | ||
| 33053697 | 임원ㆍ주요주주특정증권등소유상황보고서 | 2026-03-27 | Korean | ||
| 33053696 | 임원ㆍ주요주주특정증권등소유상황보고서 | 2026-03-27 | Korean | ||
| 33053694 | 임원ㆍ주요주주특정증권등소유상황보고서 | 2026-03-27 | Korean | ||
| 33053693 | 임원ㆍ주요주주특정증권등소유상황보고서 | 2026-03-27 | Korean | ||
| 33047004 | 정기주주총회결과 | 2026-03-26 | Korean | ||
| 33046982 | 사외이사의선임ㆍ해임또는중도퇴임에관한신고 | 2026-03-26 | Korean | ||
| 33046944 | 주식매수선택권부여에관한신고 | 2026-03-26 | Korean | ||
| 33011888 | 증권발행결과(자율공시) (제6회차 CB)) | 2026-03-23 | Korean | ||
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Adlai Nortye Ltd.
A clinical-stage biopharma firm developing cancer immunothe…
|
ANL | KY | Manufacturing |
|
ADLINE CHEM LAB LIMITED
Produces APIs, chemical intermediates, and specialty chemic…
|
524604 | IN | Manufacturing |
|
ADMA BIOLOGICS, INC.
Biopharmaceutical company that develops and manufactures pl…
|
ADMA | US | Manufacturing |
|
Advectus Life Sciences Inc.
Advances drug delivery systems using proprietary nanopartic…
|
AVXSF | CA | Manufacturing |
|
Adverum Biotechnologies, Inc.
A clinical-stage company developing gene therapies for ocul…
|
ADVM | US | Manufacturing |
|
Advicenne
A specialty pharmaceutical company developing treatments fo…
|
ALDVI | FR | Manufacturing |
|
AegirBio AB
A diagnostics company specializing in therapeutic drug moni…
|
AEGIR | SE | Manufacturing |
|
Aelis Farma
Biopharmaceutical company developing CB1 receptor inhibitor…
|
AELIS | FR | Manufacturing |
|
AEON Biopharma, Inc.
Clinical-stage company developing therapeutic applications …
|
AEON | US | Manufacturing |
|
Aequus Pharmaceuticals Inc.
Developing and commercializing specialty pharmaceutical pro…
|
AQS | CA | Manufacturing |
G2GBIO, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/17535/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=17535 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=17535 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=17535 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 17535}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for G2GBIO, Inc. (id: 17535)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.